Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

As you get older, your eyes change ... 10 people who have macular degeneration, one or two will get wet AMD. But spotting the wet AMD symptoms early will help you get treatment and prevent ...

Wet macular degeneration is a specific ... you may need to take antibiotic eye drops and injections may be less frequent after the initial treatment. Some of the anti-VEGF drugs prescribed for ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

It is caused by abnormal blood vessel growth (a condition referred to as 'wet' macular degeneration) or atrophy and accumulation of debris ('dry' macular degeneration), both of which damage the ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...